NEW YORK, Dec. 15 (GenomeWeb News) - CombiMatrix and partner Nanomaterials Discovery Corporation have created a prototype workstation for the combinatorial discovery and development of new nanomaterials, the firms said today.
The news, which is considered a milestone by the partners, caused shares in CombiMatrix yesterday to close up 10.35 percent at $4.05 in unusually heavy volume.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: genetic target for urothelial bladder cancer treatment, and more.
At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.
Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.
Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.